Squarepoint’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.77M Buy
121,857
+8,000
+7% +$357K ﹤0.01% 1814
2026
Q1
$3.87M Buy
113,857
+80,291
+239% +$3.74M ﹤0.01% 1698
2025
Q4
$0 Hold
33,566
﹤0.01% 4847
2025
Q3
$0 Buy
+33,566
New +$1.62M ﹤0.01% 4948
2017
Q2
Sell
-5,054
Closed -$229K 1789
2017
Q1
$229K Sell
5,054
-203
-4% -$8.61K 0.01% 1222
2016
Q4
$213K Buy
+5,257
New +$207K 0.01% 1396

Other funds holding SNY

Squarepoint's SNY Position: Q2 2026 in Review

Squarepoint increased its Sanofi (SNY) stake by 7% in Q2 2026, buying an estimated $357K and bringing the position to 121,857 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Squarepoint first reported a position in SNY in Q4 2016 and has held it in 6 quarters since. The position peaked at $3.87M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Squarepoint held 121,857 shares of Sanofi worth $3.77M as of Q2 2026.
  • Squarepoint bought 8,000 Sanofi shares in Q2 2026, an estimated $357K.
  • Sanofi made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1814 holding.
  • Squarepoint first reported a position in Sanofi in Q4 2016 and has held it in 6 quarters since.
  • Squarepoint's Sanofi position peaked at $3.87M in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.